Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age

Journal of Pharmacology and Experimental Therapeutics

Volumn 350, Issue 2, 2014, Pages 425-434

  Shuster, Diana L ^a   Risler, Linda J ^a   Liang, Chao Kang J ^a   Rice, Kenneth M ^a   Shen, Danny D ^a   Hebert, Mary F ^a,b   Thummel, Kenneth E ^a   Mao, Qingcheng ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; GLIBENCLAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; FEMALE; FETUS; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIVER CLEARANCE; LIVER MICROSOME METABOLISM; MASS SPECTROMETRY; MOTHER FETUS RELATIONSHIP; MOUSE MODEL; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RETROORBITAL DRUG ADMINISTRATION;

ANIMALS; AREA UNDER CURVE; CYTOCHROME P-450 CYP3A; FEMALE; FETUS; GESTATIONAL AGE; GLYBURIDE; HYPOGLYCEMIC AGENTS; METABOLIC CLEARANCE RATE; MICE; PREGNANCY; PREGNANCY, ANIMAL;

EID: 84905002518     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.213470     Document Type: Article

References (37)

1. Aleksunes LM, Cui Y, and Klaassen CD (2008) Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta. Drug Metab Dispos 36:1960-1970.
2. American College of Obstetricians and Gynecologists Committee on Practice Bulletins - Obstetrics (2001) Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 98:525-538.
3. Anderson GD (2005) Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 44:989-1008.
4. Balant L, Fabre J, Loutan L, and Samimi H (1979) Does 4-trans-hydroxy-glibenclamide show hypoglycemic activity? Arzneimittelforschung 29:162-163.
5. Feghali MN and Mattison DR (2011) Clinical therapeutics in pregnancy. J Biomed Biotechnol 2011:783528.
6. Gedeon C, Anger G, Lubetsky A, Miller MP, and Koren G (2008a) Investigating the potential role of multi-drug resistance protein (MRP) transporters in fetal to maternal glyburide efflux in the human placenta. J Obstet Gynaecol 28:485-489.
7. Gedeon C, Anger G, Piquette-Miller M, and Koren G (2008b) Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta. Placenta 29:39-43.
8. Gedeon C, Behravan J, Koren G, and Piquette-Miller M (2006) Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta 27: 1096-1102.
9. Halekoh U, Hojsgaard S, and Yan J (2006) The R Package geepack for generalized estimating equations. J Stat Softw 15:1-11.
10. HAPO Study Cooperative Research Group (2002) The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Int J Gynaecol Obstet 78:69-77.
11. Hebert MF, Easterling TR, Kirby B, Carr DB, Buchanan ML, Rutherford T, Thummel KE, Fishbein DP, and Unadkat JD (2008) Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther 84:248-253.
12. Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, Caritis SN, Miodovnik M, Mattison DR, and Unadkat JD, et al; Obstetric-Fetal Pharmacology Research Unit Network (2009) Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 85:607-614.
13. Hemauer SJ, Patrikeeva SL, Nanovskaya TN, Hankins GD, and Ahmed MS (2010) Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. Am J Obstet Gynecol 202:383.e1-e383.e7.
14. Jovanovic L and Pettitt DJ (2001) Gestational diabetes mellitus. JAMA 286: 2516-2518.
15. Klieger C, Pollex E, Kazmin A, and Koren G (2009) Hypoglycemics: pharmacokinetic considerations during pregnancy. Ther Drug Monit 31:533-541.
16. Langer O, Conway DL, Berkus MD, Xenakis EM, and Gonzales O (2000) A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343:1134-1138.
17. Mager H and Göller G (1998) Resampling methods in sparse sampling situations in preclinical pharmacokinetic studies. J Pharm Sci 87:372-378.
18. Mathias AA, Hitti J, and Unadkat JD (2005) P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 289:R963-R969.
19. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, and Oats JN, et al (2007) Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30 (Suppl 2):S251-S260.
20. Meyer zu Schwabedissen HE, Grube M, Dreisbach A, Jedlitschky G, Meissner K, Linnemann K, Fusch C, Ritter CA, Völker U, and Kroemer HK (2006) Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab Dispos 34:524-533.
21. Nanovskaya TN, Nekhayeva I, Hankins GD, and Ahmed MS (2006) Effect of human serum albumin on transplacental transfer of glyburide. Biochem Pharmacol 72:632-639.
22. Naraharisetti SB, Kirby BJ, Hebert MF, Easterling TR, and Unadkat JD (2007) Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: an OPRU Network study. J Chromatogr B Analyt Technol Biomed Life Sci 860:34-41.
23. Paglia MJ and Coustan DR (2011) Gestational diabetes: evolving diagnostic criteria. Curr Opin Obstet Gynecol 23:72-75.
24. Paine MF, Khalighi M, Fisher JM, Shen DD, Kunze KL, Marsh CL, Perkins JD, and Thummel KE (1997) Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther 283: 1552-1562.
25. R Core Team (2014) R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria.
26. Ravindran S, Zharikova OL, Hill RA, Nanovskaya TN, Hankins GD, and Ahmed MS (2006) Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons. Biochem Pharmacol 72:1730-1737.
27. Rydberg T, Jönsson A, Røder M, and Melander A (1994) Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans. Diabetes Care 17:1026-1030.
28. Shuster DL, Bammler TK, Beyer RP, Macdonald JW, Tsai JM, Farin FM, Hebert MF, Thummel KE, and Mao Q (2013) Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant mice. Drug Metab Dispos 41:332-342.
29. Thummel KE, Kharasch ED, Podoll T, and Kunze K (1993) Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1. Drug Metab Dispos 21:350-357.
30. Wang H, Wu X, Hudkins K, Mikheev A, Zhang H, Gupta A, Unadkat JD, and Mao Q (2006) Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors. Am J Physiol Endocrinol Metab 291:E1295-E1304.
31. Westfall PH and Young SS (1993) Resampling-Based Multiple Testing: Examples and Methods for P-Value Adjustment, Wiley, New York.
32. Yan J and Fine J (2004) Estimating equations for association structures. Stat Med 23:859-874, discussion 875-877, 879-880.
33. Zhang H, Wu X, Wang H, Mikheev AM, Mao Q, and Unadkat JD (2008) Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course. Mol Pharmacol 74:714-723.
34. Zharikova OL, Fokina VM, Nanovskaya TN, Hill RA, Mattison DR, Hankins GD, and Ahmed MS (2009) Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide. Biochem Pharmacol 78:1483-1490.
35. Zhou L, Naraharisetti SB, Liu L, Wang H, Lin YS, Isoherranen N, Unadkat JD, Hebert MF, and Mao Q (2010a) Contributions of human cytochrome P450 enzymes to glyburide metabolism. Biopharm Drug Dispos 31:228-242.
36. Zhou L, Naraharisetti SB, Wang H, Unadkat JD, Hebert MF, and Mao Q (2008) The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol 73:949-959.
37. Zhou L, Zhang Y, Hebert MF, Unadkat JD, and Mao Q (2010b) Increased glyburide clearance in the pregnant mouse model. Drug Metab Dispos 38:1403-1406.